NRO.PA
Price:
$44.9
Market Cap:
$1.09B
Neurones S.A., an information technology (IT) services company, provides infrastructure, application, and consulting services in France and internationally. Its infrastructure services include infrastructure management, clouds, user support, DevOps, cybersecurity, IT service management, information system governance, and automation. The company also provides application services in the areas of SAP integration and outsourcing; mobility, data, IoT, digital, agile, UX/UI, and DevOps; IT consulting for finance, big data, AI and blockchain; content management, business process management, paperless process; and IT training and working with change management. In addition, it offers consulting ser...[Read more]
Industry
Information Technology Services
IPO Date
2000-05-24
Stock Exchange
EURONEXT
Ticker
NRO.PA
According to Neurones S.A.’s latest financial reports and current stock price. The company's current PE Ratio is 22.56. This represents a change of 117.76% compared to the average of 10.36 of the last 4 quarters.
The mean historical PE Ratio of Neurones S.A. over the last ten years is 20.60. The current 22.56 PE Ratio has changed 10.85% with respect to the historical average. Over the past ten years (40 quarters), NRO.PA's PE Ratio was at its highest in in the March 2012 quarter at 17.16. The PE Ratio was at its lowest in in the December 2009 quarter at 0.
Average
20.60
Median
20.58
Minimum
16.20
Maximum
25.30
Discovering the peaks and valleys of Neurones S.A. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 33.03%
Maximum Annual PE Ratio = 25.30
Minimum Annual Increase = -30.16%
Minimum Annual PE Ratio = 16.20
Year | PE Ratio | Change |
---|---|---|
2023 | 25.18 | 17.18% |
2022 | 21.49 | -11.95% |
2021 | 24.40 | 33.03% |
2020 | 18.35 | 12.96% |
2019 | 16.24 | -8.08% |
2018 | 17.67 | -30.16% |
2017 | 25.30 | 17.63% |
2016 | 21.51 | 9.36% |
2015 | 19.67 | 21.38% |
2014 | 16.20 | 0.54% |
The current PE Ratio of Neurones S.A. (NRO.PA) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
23.69
5-year avg
21.13
10-year avg
20.60
Neurones S.A.’s PE Ratio is greater than SII S.A. (11.20), greater than Aubay Société Anonyme (18.07), greater than Infotel SA (17.73), less than Precia S.A. (86.44), greater than IT Link SA (8.46),
Company | PE Ratio | Market cap |
---|---|---|
11.20 | $1.36B | |
18.07 | $596.45M | |
17.73 | $294.56M | |
86.44 | $151.25M | |
8.46 | $43.00M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Neurones S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Neurones S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Neurones S.A.'s PE Ratio?
How is the PE Ratio calculated for Neurones S.A. (NRO.PA)?
What is the highest PE Ratio for Neurones S.A. (NRO.PA)?
What is the 3-year average PE Ratio for Neurones S.A. (NRO.PA)?
What is the 5-year average PE Ratio for Neurones S.A. (NRO.PA)?
How does the current PE Ratio for Neurones S.A. (NRO.PA) compare to its historical average?